Slide 1: Faster, more accurate gold analysis
Faster, more accurate gold analysis 1H FY25 Financial Results 20 February 2025 Dirk Treasure, Managing Director and CEO Brett Coventry, CFO
Slide 2: Important notice
Important notice The material in this presentation has been prepared by Chrysos Corporation Limited (ASX: C79) (“Chrysos” or the “Group") and is general background information about Chrysos’ current activities as at the date of this presentation. The information is given in summary form and does not
Slide 3: Chrysos – revolutionising the global mining industry
Chrysos – revolutionising the global mining industry Chrysos is a global provider of novel assay services through its proprietary PhotonAssayTM technology Disruptive Minerals Analysis Service and Lease Model with Industry Accepted Technology Technology Tier 1 Counterparties Displacing Traditional Fi
Slide 4: Financial and operating highlights
Financial and operating highlights 1H FY25 EBITDA of $5.7m, reflecting 150% growth YoY $29.1m $5.7m Total Revenue1 EBITDA • MMAP Revenue of $25.8m, AAC Revenue of $3.3m • 20% EBITDA margin (up from 12% in 1H FY24) • Secure Long-Term MMAP Revenue accounts for 89% of Total Revenue • Improving operatio
Slide 5: Market reach extends across key miners
Market reach extends across key miners Ongoing adoption by global miners drives volume growth Top 15 Gold Producing Companies (2023) Samples Processed Actively using PhotonAssayTM 1,800,000 Testwork and other engagement Future potential 1,600,000 1,400,000 Number of PhotonAssays 1,200,000 Barrick 1,
Slide 6: Executing on our global PhotonAssay roll out
Executing on our global PhotonAssayTM roll out Strengthening relationships with global miners and laboratory companies 34 Units Deployed ■ Five new units deployed, bringing the total to 34, including: ■ Continued deployment to one of the world’s biggest gold miners, Barrick, with MSALABS’ initial tw
Slide 7: 1H FY25 Financial Summary
1H[Insert] FY25 Financial Summary
Slide 8: Diversifying regional revenues
Diversifying regional revenues Continued global adoption Revenue1 by Region 54% $35,000 $30,000 ■ Revenue1 of $29.1m reflects an increase of 54% YoY driven primarily by international revenue and sample volume growth Revenue per Region $25,000 ■ Non-APAC YoY revenue grew 59% and 270% from EMEA and th
Slide 9: Top line momentum continuing
Top line momentum continuing Secure forecastable revenue accounts for 89% of 1H FY25 Total Revenue MMAP, AAC and Other Revenue ■ Minimum Monthly Assay Payments (MMAP) provide predictable and $35,000 sustainable minimum revenue $29.1m $30,000 ■ 1H FY25 MMAP was $25.8m, up 56% on 1H FY24 ($16.6m) $25,
Slide 10: Revenue & profitability
Revenue & profitability 1H FY25 Results Strong Revenue Growth #039;000 1H FY24 1H FY25 Revenue and other income ■ Total Revenue of $29.1m continues to grow in line with deployment of Revenue 18,904 29,075 PhotonAssayTM units Other revenue 52 26 ■ PhotonAssayTM costs reflect Chysos’ strategy to grow in-
Slide 11: Cash flow summary
Cash flow summary Operationally cash flow positive in the half year Cash flow summary Cash flow ■ Operating Cashflow increase of 10x YoY as the business $000’s 1HY FY24 1HY FY25 continues to scale across the globe EBITDA 2,278 5,687 ■ Capital expenditure elevated due to the timing of payments Non-ca
Slide 12: Balance sheet
Balance sheet $121.9m funds available for PhotonAssayTM unit deployment1 Strong balance sheet $000’s 30-Jun-24 31-Dec-24 Assets ■ As at 31 December 2024 Cash and cash equivalents 61,067 26,935 ■ Total debt available to the Company is $95 million1 Trade and other receivables 18,054 21,714 Other curre
Slide 13: Outlook
CHRYSOS CORPORATION Assays at the speed of light CHR COR}
Slide 14: The Chrysos Opportunity
The Chrysos Opportunity Vision to become the world’s leading provider of innovative assay services and technologies Total Addressable Market (TAM) ▪ Convert gold mining projects in all key mining 700 hubs to PhotonAssayTM 610 Units 600 ▪ Focus on improved customer outcomes to drive sample volumes Ph
Slide 15: PhotonAssay beyond gold
PhotonAssayTM beyond gold Unlocking further market opportunities Near Term Development Commercially Available Detectable Elements Optimising Mine Sites Detectable Elements ■ Concurrent moisture ■ Solution analysis Broader Potential ■ Other base metals Current / Core PhotonAssayTM ■ Rare earths appli
Slide 16: FY25 Guidance
FY25 Guidance Forecastable revenue model FY25 Guidance1: ■ Revenue is tracking at the lower end of the $60m to $70m guidance range ■ EBITDA is tracking below the midpoint of the $9m to $19m guidance range 1. Constant currency assumptions (AUD:USD 0.665, AUD:CAD 0.907, AUD:GBP 0.522, AUD:NZD 1.083),
Slide 17: Summary
Summary Chrysos PhotonAssayTM well positioned for sustainable growth ■ Strong financial performance in 1H FY25: ■ 54% YoY increase in Total Revenue1 ■ 150% YoY EBITDA growth - improving operating efficiencies in line with revenue growth ■ Significant EBITDA margin expansion to 20% ■ Six new lease ag
Slide 18: About Chrysos
CHRYSOS CORPORATION Assays at the speed of light About Chrysos
Slide 19: Our commercialisation journey
Our commercialisation journey The outcome of 20+ years of research and development International Prototype Complete JORC and NI43-101 New Customer deployment continues 1st PhotonAssayTM Max unit Companies cite PhotonAssayTM Announcements Established Canadian & data in market announcements Barrick Bu
Slide 20: Delivering tangible benefits for miners
Delivering tangible benefits for miners PhotonAssayTM enables timely decision making and additional gold recovery The opportunity… PhotonAssayTM is embedded in the mining value chain PhotonAssayTM Value Add ■ Each year global miners are Exploration Fast turnaround for mine estimated to lose >$2.0 bi
Slide 21: PhotonAssay technology
PhotonAssayTM technology Best in class gold assaying with measurable benefits over traditionally used methods PhotonAssayTM vs. Traditional Fire Assay1 PhotonAssayTM value proposition Fire Assay PhotonAssayTM Faster turnaround Lower costs Simple to operate Results in as little as 2 minutes Time per
Slide 22: Safe & sustainable analysis
Safe & sustainable analysis Meaningful OH&S and environmental benefits As of 31 December 2024, Chrysos PhotonAssayTM has achieved: PhotonAssayTM provides improved OH&S through the elimination of hazardous chemicals, lead exposure, and the ultra-high temperatures used in conventional fire assay 6528
Slide 23: High barriers to entry
High barriers to entry High barriers to entry supported by global IP rights Barriers to competitive entry Long-term leases with Protected by global guaranteed minimums, IP rights embedded at customer site 20+ years of R&D and Superior product to the investment in technology alternative Attractive va
Slide 24: Differentiated lease & operating models
Differentiated lease & operating models Best-fit approach broadens operational flexibility and applicability Unit Leased by Laboratory to Service Unit Leased by Laboratory to Service Unit Leased by Miner & Unit Leased & Operated by Miner Multiple Mining Customers a Specific Mining Operation Operated
Slide 25: Unit lifecycle & financial profile
Unit lifecycle & financial profile Unit economics are the underlying strength behind Chrysos’ business -18 Months -9 Months 8-12 weeks 5+5+5+5 year lease model 20 Years Long Lead Time • Detector station components Key steps Initial lease, renewal, recontract Refurbishment or re-use Components integr
Slide 26: Experienced leadership team
Experienced leadership team Supported by a well-respected and tenured board Senior leadership team Board of Directors Dirk Treasure Rob Adamson Kerry Gleeson Founding CEO & Managing Director Founder & Chairman Director • Metallurgist with a background in both • 20+ years’ experience in mining and •
Slide 27: Thank you
Thank you For more information, please visit chrysoscorp.com or contact us at investors@chrysoscorp.com